APUA Consultant Panel and Scientific Advisory Board
APUA’s Scientific Advisory Board and roster of expert consultants are based in 54 countries - 25 in the developing world. This panel includes recognized experts on antimicrobial development, use, and resistance, with sub-specialties in pharmaceutical management, pharmacoeconomics, microbiology, internal medicine, pediatrics, public health, epidemiology, veterinary medicine/animal health, pharmacology, infection control/quality improvement, surveillance, provider training, clinical guidelines development, policy analysis, consumer education, and program administration. Many have field experience in developing countries and are fluent in Spanish, French, and many other languages.
Consultant Panel
Aníbal Sosa, M.D. Professor Emeritus, Medical Microbiology and Tropical Diseases, University of Zulia School of Medicine, Tufts School of Medicine. Former Director of APUA International Chapter Programs.
Mirella Zulueta, M.D. ,Ph.D. Former Director of APUA Translational Medicine.
Scientific Advisory Board
Jacques F. Acar, M.D., Professor Emeritus, Microbiologie Medicale Foundation, Hopital Saint-Joseph, Paris, France
Werner Arber, Ph.D., Professor Emeritus, University of Basel, Switzerland (1978 Nobel Prize in Physiology or Medicine)
Fernando Baquero Mochale, M.D., Director,Servicio de Microbiologia, Hospital “Ramon y Cajal”, Madrid, Spain
Michael L. Bennish, M.D., Director, Africa Centre for Health and Population Studies in Mtubatuba, South Africa, and Professor, Departments of Medicine & Pediatrics, Tufts-New England Medical Center, Boston, Mass., USA
Patrice Courvalin, M.D., FRCP, Head of Antibacterial Agents Unit and of the (French) National Reference Center for Antibiotics, Institut Pasteur, Paris, France
Jose Ramiro Cruz, Ph.D., Regional Advisor (Guatemala) for Laboratory and Blood Services, Unit of Essential Medicines, Vaccines & Technologies; Pan American Health Organization; Washington DC
Iwan Darmansjah, M.D., Professor Emeritus, Department of Pharmacology, University of Indonesia, Jakarta, Indonesia, and Chair of the Subcommittee on Evaluation of Drugs for Safety & Efficacy, Indonesian Department of Health
Julian Davies, Ph.D., Professor Emeritus, University of British Columbia, and Vice President and Chief Scientific Officer, TerraGen Diversity, Inc., Vancouver, BC, Canada
Stanley Falkow, Ph.D., Cahill Professor Microbiology and Immunology; Geographic Medicine; Infectious Diseases, Stanford University School of Medicine, Stanford, CA
Paul Farmer, M.D., Co-founder, Partners In Health; Presley Professor of Social Medicine and Chair, Department of Global Health and Social Medicine, Harvard Medical School; and Chief, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Mass., USA
Walter Gilbert, Ph.D., Loeb University Professor, Department of Molecular & Cellular Biology, Harvard University, Cambridge, Mass., USA (1980 Nobel Prize in Chemistry)
Herman Goossens, Ph.D., Director, Department of Clinical Microbiology, University Hospital, Antwerp, Belgium, and Project Leader of ESAC-European Surveillance on Antimicrobial Consumption
Sherwood L. Gorbach, M.D., Professor, Community Health & Medicine, Tufts University School of Medicine, Boston, Mass., USA
Ian M. Gould, Ph.D., Consultant Microbiologist, Aberdeen Royal Hospital, Aberdeen, Scotland
David Heymann, M.D., Chair of the Health Protection Agency in London, Head of the Centre on Global Health Security at Chatham House and Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine
George Jacoby, M.D., Infectious Disease Section, Lahey Clinic, Burlington, Mass., USA and Associate Professor of Medicine, Harvard Medical School
Sam Kariuki, Ph.D., Chief Research Officer and Head of Department, Centre for Microbiology Research at the Kenya Medical Research Institute (KEMRI)
Ellen L. Koenig, M.D., Principal Investigator, Institutto Dominicao De Estudios Virologicos (IDEV)
Calvin M. Kunin, M.D., FACP, Clinical Professor, Department of Infectious Disease Section, University of Arizona
Jacobo Kupersztoch, Ph.D., Executive Director, Centro Communitario Mexicano, Dallas, Texas, USA
Stephen A. Lerner, M.D., Professor of Medicine, Division of Infectious Diseases, and Associate Dean, Wayne State University School of Medicine, Detroit, Michigan, USA
Jay A. Levy, M.D., Director, Laboratory for Tumor and AIDS Virus Research, and Professor, University of California, San Francisco, California, USA
Donald E. Low, M.D., FRCPC, Microbiologist-in-Chief, Mt. Sinai & Princess Margaret Hospitals, and Professor, University of Toronto, Ontario, Canada,
Scott McEwen, D.V.M., D.V.Sc., ACVP, Professor, Department of Population Medicine, Ontario Veterinary College of the University of Guelph, Ontario, Canada
Jos. W.M. van der Meer, M.D., FRCP, Professor of Internal Medicine and Chairman of the Division of General Internal Medicine, University Medical Center of Nijmegen, The Netherlands
Richard P. Novick, M.D., Professor of Microbiology and Medicine, New York University Medical Center, New York, NY, USA
Ayo Oduola, Ph.D., Functional Coordinator Strategic and Discovery Research, Special Programme for Research and Training in Tropical Diseases, World Health Organization
Iruka Okeke, Ph.D., Assistant Professor of Biology, Haverford College, Haverford, Pennsylvania, USA & Nigeria
Maria Eugenia Pinto, M.D., Faculty of Medicine/Microbiology, University of Chile, Santiago, Chile
Vidal Rodriguez-Lemoine, M.D., Director, Centro Venezolano de Colecciones de Microorganismos, Universidad Central de Venezuela, Caracas, Venezuela
José Ignacio Santos, M.D., Director, National Immunization Council, Colonia Merced Gomez D.F., Mexico, and Professor of Experimental Medicine and Infectious Diseases at the School of Medicine, UNAM
Mervyn Shapiro, Ph.D., ChB., Director, Department of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel
K.B. Sharma, Ph.D., Director, Centre for Infectious Disease Education & Research, New Delhi, India
Atef M. Shibil, Ph.D., Professor of Microbiology, King Saud University College of Pharmacy, Riyadh, Saudi Arabia
E. John Threlfall, Ph.D., Head, Antibiotic Resistance/Molecular Epidemiology Unit, Laboratory of Enteric Pathogens, Health Protection Agency, London, England
Alexander Tomasz, M.D., Microbiology Laboratory, Rockefeller University, New York, New York, USA
Thelma E. Tupasi, M.D., Head, Infectious Disease Section, Makati Medical Center, Manila, The Philippines
Anne K. Vidaver, Ph.D., Head, Department of Plant Pathology, University of Nebraska, Lincoln, Nebraska, USA
Fu Wang, M.D., Honorary Director, Institute of Antibiotics, Shanghai Medical University, and doctor in the Hua Shan Hospital, Shanghai, China
Thomas Wellems, M.D., Ph.D., Acting Co-chief, Laboratory of Parasitic Diseases, and Laboratory of Malaria and Vector Research, National Institutes of Health/ National Institute of Allergy & Infectious Diseases, Bethesda, Maryland, USA
Bernd Wiedemann, M.D., Professor, Pharmazeutisch Microbiolgie, University at Bonn, Germany.
|
